| Literature DB >> 33294994 |
Qi Wu1, Jinglu Zhao1, Yi Zheng1, Xiaoli Xie1, Qiuming He1, Yun Zhu1, Ning Wang1, Lihua Huang1, Lifeng Lu1, Tuqun Hu1, Jixiao Zeng1, Huimin Xia1, Yan Zhang1, Wei Zhong1.
Abstract
INTRODUCTION: Hirschsprung disease (HSCR), characterized by the defective migration of enteric neural crest cells, is a severe congenital tract disease in infants. Its etiology is not clear at present, although a genetic component plays an important role in its etiology. Many studies focused on the polymorphisms of microRNA (miRNA) in several disease progressions have been reported, including HSCR. However, the findings remain inconclusive. The present study aimed to explore the association of genetic variants in miRNAs and HSCR susceptibility in Southern Chinese children.Entities:
Keywords: Hirschsprung's disease; Southern Chinese Children; association; genetic variants; microRNAs
Mesh:
Substances:
Year: 2021 PMID: 33294994 PMCID: PMC7900950 DOI: 10.1002/jgm.3301
Source DB: PubMed Journal: J Gene Med ISSN: 1099-498X Impact factor: 4.565
Associations between selected polymorphism and Hirschsprung disease risk in Southern Chinese children
| CHR | SNP | Gene | BP | A1/A2 | F_A | F_U | Model | OR |
|
|---|---|---|---|---|---|---|---|---|---|
| 5 | rs2431697 | MIR3142 | 160,452,971 | C/T | 0.12 | 0.13 | ALLELIC | 0.93 (0.80–1.08) | 0.35 |
| ADD | 0.90 (0.66–1.22) | 0.51 | |||||||
| REC | 0.82 (0.45–1.52) | 0.54 | |||||||
| DOMDEV | 1.04 (0.74–1.46) | 0.83 | |||||||
| 5 | rs2431097 | MIR3142 | 160,463,878 | T/C | 0.24 | 0.24 | ALLELIC | 1.03 (0.91–1.17) | 0.60 |
| ADD | 1.04 (0.89–1.22) | 0.62 | |||||||
| REC | 1.08 (0.79–1.47) | 0.65 | |||||||
| DOMDEV | 0.98 (0.80–1.20) | 0.87 | |||||||
| 5 | rs57095329 |
PTTG1, MIR3142 | 160,467,840 | G/A | 0.21 | 0.21 | ALLELIC | 0.98 (0.86–1.11) | 0.77 |
| ADD | 0.99 (0.82–1.18) | 0.89 | |||||||
| REC | 0.98 (0.69–1.40) | 0.92 | |||||||
| DOMDEV | 0.99 (0.79–1.23) | 0.92 | |||||||
| 5 | rs2910164 | MIR146A | 160,485,411 | G/C | 0.38 | 0.37 | ALLELIC | 1.01 (0.91–1.13) | 0.82 |
| ADD | 0.99 (0.88–1.11) | 0.84 | |||||||
| REC | 0.93 (0.75–1.16) | 0.53 | |||||||
| DOMDEV | 1.10 (0.94–1.29) | 0.25 | |||||||
| 18 | rs8096901 |
MIR4318, LINC00669 | 38,065,879 | T/C | 0.30 | 0.32 | ALLELIC | 0.91 (0.82–1.02) | 0.12 |
| ADD | 0.87 (0.76–0.99) |
| |||||||
| REC | 0.76 (0.59–0.98) |
| |||||||
| DOMDEV | 1.13 (0.95–1.35) | 0.16 |
CHR, chromosome; SNP, single nucleotide polymorphism; BP, base pair where the SNP is located; A1/A2 indicates the minor allele and major allele to disease; F_A/F_U, minor allele frequency of the SNP in cases or controls; ALLELIC, ADD, REC and DOMDEV indicate the association test following allelic, additive, recessive, dominant models; OR, odds ratio. The p value indicates the significance based on allelic each association test model, respectively, adjusted for age and genders. The use of bold in p‐value means the result is meaningful statistically.
The association results of selected SNPs with different subclinical features classified by aganglionosis length, including short‐length (S‐HSCR), long‐length (L‐HSCR) and total colonic aganglionosis (TCA)
| CHR | SNP | BP | A1/A2 | F_A | F_U | Model | OR |
|
|---|---|---|---|---|---|---|---|---|
| S‐HSCR | ||||||||
| 5 | rs2431697 | 160,452,971 | C/T | 0.13 | 0.13 | ALLELIC | 0.95 (0.80–1.13) | 0.55 |
| ADD | 1.01 (0.84–1.20) | 0.96 | ||||||
| REC | 1.01 (0.71–1.43) | 0.97 | ||||||
| DOMDEV | 1.01 (0.81–1.26) | 0.95 | ||||||
| 5 | rs2431097 | 160,463,878 | T/C | 0.24 | 0.24 | ALLELIC | 1.01 (0.88–1.15) | 0.90 |
| ADD | 0.96 (0.69–1.33) | 0.79 | ||||||
| REC | 0.93 (0.48–1.79) | 0.82 | ||||||
| DOMDEV | 0.99 (0.68–1.43) | 0.96 | ||||||
| 5 | rs57095329 | 160,467,840 | G/A | 0.20 | 0.21 | ALLELIC | 0.97 (0.84–1.11) | 0.62 |
| ADD | 1.02 (0.90–1.16) | 0.75 | ||||||
| REC | 0.99 (0.78–1.26) | 0.94 | ||||||
| DOMDEV | 1.07 (0.90–1.28) | 0.42 | ||||||
| 5 | rs2910164 | 160,485,411 | G/C | 0.38 | 0.37 | ALLELIC | 1.04 (0.92–1.17) | 0.53 |
| ADD | 0.93 (0.73–1.18) | 0.55 | ||||||
| REC | 0.90 (0.56–1.44) | 0.65 | ||||||
| DOMDEV | 0.95 (0.72–1.26) | 0.73 | ||||||
| 18 | rs8096901 | 38,065,879 | T/C | 0.30 | 0.32 | ALLELIC | 0.90 (0.79–1.02) | 0.096 |
| ADD | 0.85 (0.73–0.99) |
| ||||||
| REC | 0.74 (0.55–0.98) |
| ||||||
| DOMDEV | 1.14 (0.94–1.39) | 0.18 | ||||||
| L‐HSCR | ||||||||
| 5 | rs2431697 | 160,452,971 | C/T | 0.13 | 0.13 | ALLELIC | 0.95 (0.72–1.24) | 0.70 |
| ADD | 1.13 (0.87–1.47) | 0.35 | ||||||
| REC | 1.28 (0.77–2.13) | 0.34 | ||||||
| DOMDEV | 0.88 (0.63–1.23) | 0.46 | ||||||
| 5 | rs2431097 | 160,463,878 | T/C | 0.25 | 0.24 | ALLELIC | 1.06 (0.86–1.31) | 0.56 |
| ADD | 0.66 (0.32–1.36) | 0.26 | ||||||
| REC | 0.43 (0.10–1.84) | 0.26 | ||||||
| DOMDEV | 1.55 (0.72–3.36) | 0.26 | ||||||
| 5 | rs57095329 | 160,467,840 | G/A | 0.22 | 0.21 | ALLELIC | 1.04 (0.83–1.29) | 0.74 |
| ADD | 0.95 (0.77–1.17) | 0.65 | ||||||
| REC | 0.89 (0.60–1.31) | 0.56 | ||||||
| DOMDEV | 1.09 (0.82–1.44) | 0.55 | ||||||
| 5 | rs2910164 | 160,485,411 | G/C | 0.37 | 0.37 | ALLELIC | 0.98 (0.81–1.18) | 0.80 |
| ADD | 0.86 (0.57–1.29) | 0.46 | ||||||
| REC | 0.76 (0.34–1.69) | 0.50 | ||||||
| DOMDEV | 1.05 (0.66–1.69) | 0.83 | ||||||
| 18 | rs8096901 | 38,065,879 | T/C | 0.33 | 0.32 | ALLELIC | 1.04 (0.85–1.26) | 0.72 |
| ADD | 0.99 (0.79–1.24) | 0.94 | ||||||
| REC | 0.93 (0.60–1.43) | 0.73 | ||||||
| DOMDEV | 1.13 (0.84–1.53) | 0.41 | ||||||
| TCA | ||||||||
| 5 | rs2431697 | 160,452,971 | C/T | 0.1 | 0.13 | ALLELIC | 0.75 (0.45–1.25) | 0.26 |
| ADD | 0.83 (0.30–2.29) | 0.73 | ||||||
| REC | 0.74 (0.10–5.58) | 0.77 | ||||||
| DOMDEV | 0.87 (0.28–2.69) | 0.81 | ||||||
| 5 | rs2431097 | 160,463,878 | T/C | 0.27 | 0.24 | ALLELIC | 1.17 (0.82–1.67) | 0.39 |
| ADD | 1.27 (0.84–1.92) | 0.27 | ||||||
| REC | 1.57 (0.70–3.51) | 0.28 | ||||||
| DOMDEV | 0.84 (0.48–1.46) | 0.53 | ||||||
| 5 | rs57095329 | 160,467,840 | G/A | 0.19 | 0.21 | ALLELIC | 0.90 (0.60–1.33) | 0.59 |
| ADD | 0.89 (0.49–1.61) | 0.69 | ||||||
| REC | 0.82 (0.25–2.65) | 0.73 | ||||||
| DOMDEV | 1.02 (0.50–2.07) | 0.97 | ||||||
| 5 | rs2910164 | 160,485,411 | G/C | 0.34 | 0.37 | ALLELIC | 0.88 (0.63–1.23) | 0.46 |
| ADD | 0.79 (0.52–1.21) | 0.28 | ||||||
| REC | 0.61 (0.28–1.35) | 0.22 | ||||||
| DOMDEV | 1.33 (0.79–2.24) | 0.29 | ||||||
| 18 | rs8096901 | 38,065,879 | T/C | 0.26 | 0.32 | ALLELIC | 0.76 (0.53–1.09) | 0.14 |
| ADD | 0.78 (0.50–1.20) | 0.26 | ||||||
| REC | 0.69 (0.29–1.61) | 0.39 | ||||||
| DOMDEV | 0.96 (0.54–1.70) | 0.89 | ||||||
CHR, chromosome; SNP, single nucleotide polymorphism; BP, base pair where the SNP is located; A1/A2 indicates the minor allele and major allele to disease; F_A/F_U, minor allele frequency of the SNP in cases or controls; ALLELIC, ADD, REC and DOMDEV indicate the association test following allelic, additive, recessive, dominant models; OR, odds ratio. The p value indicates the significance based on allelic each association test model, respectively, adjusted for age and genders. The use of bold in p‐value means the result is meaningful statistically.